Nuveen LLC Purchases New Shares in Arteris, Inc. $AIP

Key Points

• Nuveen LLC acquired approximately 50,513 shares of Arteris, Inc. valued at $349,000, representing a 0.12% stake in the company.
• Insider transactions include substantial sales by CEO K Charles Janac and COO Laurent R. Moll, with Janac's sale leading to a 33.18% decrease in his holdings.
• Arteris' stock has received a buy rating from analysts, with a revised price target of $15.00 following recent reports.

Nuveen LLC purchased a new stake in Arteris, Inc. (NASDAQ:AIP - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 50,513 shares of the company's stock, valued at approximately $349,000. Nuveen LLC owned approximately 0.12% of Arteris as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AIP. Wells Fargo & Company MN lifted its position in Arteris by 38.9% during the fourth quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock valued at $134,000 after buying an additional 3,694 shares during the period. Barclays PLC lifted its position in Arteris by 13.5% during the fourth quarter. Barclays PLC now owns 44,723 shares of the company's stock valued at $456,000 after buying an additional 5,327 shares during the period. Price T Rowe Associates Inc. MD purchased a new position in Arteris during the fourth quarter valued at $117,000. Northern Trust Corp lifted its position in Arteris by 6.6% during the fourth quarter. Northern Trust Corp now owns 224,443 shares of the company's stock valued at $2,287,000 after buying an additional 13,838 shares during the period. Finally, BNP Paribas Financial Markets purchased a new position in Arteris during the fourth quarter valued at $214,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Insider Buying and Selling

In related news, CEO K Charles Janac sold 94,245 shares of Arteris stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.49, for a total value of $1,271,365.05. Following the completion of the sale, the chief executive officer directly owned 189,785 shares in the company, valued at approximately $2,560,199.65. This trade represents a 33.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Laurent R. Moll sold 42,692 shares of Arteris stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $8.94, for a total value of $381,666.48. Following the completion of the sale, the chief operating officer owned 399,379 shares of the company's stock, valued at $3,570,448.26. The trade was a 9.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 492,989 shares of company stock worth $5,823,031 in the last three months. 29.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AIP has been the subject of several recent research reports. TD Cowen raised their price objective on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a research report on Saturday, August 30th. Finally, Rosenblatt Securities reissued a "buy" rating and set a $14.00 price objective on shares of Arteris in a research report on Wednesday, May 21st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Arteris currently has a consensus rating of "Buy" and a consensus target price of $15.00.

Arteris Price Performance

AIP opened at $8.86 on Friday. The stock has a 50-day moving average price of $9.52 and a 200-day moving average price of $8.24. The firm has a market cap of $377.88 million, a PE ratio of -10.80 and a beta of 1.44. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $14.29.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The company had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.

Arteris Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.